Synthesis of Pharmaceutically Relevant 2‐Aminotetralin and 3‐Aminochroman Derivatives via Enzymatic Reductive Amination
- 3 September 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 133 (46) , 24661-24665
Abstract
2‐Aminotetralin and 3‐aminochroman derivatives are key structural motifs present in a wide range of pharmaceutically important molecules. Herein, we report an effective biocatalytic approach towards these molecules through the enantioselective reductive coupling of 2‐tetralones and 3‐chromanones with a diverse range of primary amine partners. Metagenomic imine reductases (IREDs) were employed as the biocatalysts, obtaining high yields and enantiocomplementary selectivity for >15 examples at preparative scale, including the precursors to Ebalzotan, Robalzotan, Alnespirone and 5‐OH‐DPAT. We also present a convergent chemo‐enzymatic total synthesis of the Parkinson's disease therapy Rotigotine in 63 % overall yield and 92 % ee.Keywords
Funding Information
- H2020 European Research Council (742987)
This publication has 43 references indexed in Scilit:
- Efficient Enantioselective Synthesis of 3-Aminochroman Derivatives Through Ruthenium-Synphos Catalyzed Asymmetric HydrogenationOrganic Letters, 2011
- Practical Asymmetric Synthesis of Bioactive Aminotetralins from a Racemic Precursor Using a Regiodivergent ResolutionOrganic Letters, 2010
- Directed evolution drives the next generation of biocatalystsNature Chemical Biology, 2009
- Further Structure–Activity Relationships Study of Hybrid 7-{[2-(4-Phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol Analogues: Identification of a High-Affinity D3-Preferring Agonist with Potent in Vivo Activity with Long Duration of ActionJournal of Medicinal Chemistry, 2007
- Synthesis and Biological Evaluation of Novel Compounds within a Class of 3-Aminochroman Derivatives with Dual 5-HT1AReceptor and Serotonin Transporter AffinityJournal of Medicinal Chemistry, 2006
- Adsorbent Screening for Metal Impurity Removal in Pharmaceutical Process ResearchOrganic Process Research & Development, 2005
- An Expeditious Scalable Synthesis of (S)-2-Amino-5-methoxytetralin via ResolutionOrganic Process Research & Development, 2004
- Novel 2-Aminotetralin and 3-AminoChroman Derivatives as Selective Serotonin 5-HT7 Receptor Agonists and AntagonistsJournal of Medicinal Chemistry, 2004
- Development of a Process for a Chiral Aminochroman Antidepressant: A Case StoryOrganic Process Research & Development, 2000
- (R)‐ and (S)‐5‐hydroxy‐2‐(dipropylamino)tetralin (5‐OH DPAT): Assessment of optical purities and dopaminergic activitiesChirality, 1990